Haematocrit, type 2 diabetes, and endothelium-dependent vasodilatation of resistance vessels

European Heart Journal

Volumn 26, Issue 5, 2005, Pages 464-471

  Natali, Andrea ^a,b   Toschi, Elena ^a,b   Baldeweg, Stephanie ^c   Casolaro, Arturo ^a,b   Baldi, Simona ^a,b   Sironi, Anna Maria ^a,b   Yudkin, John S ^c   Ferrannini, Ele ^a,b  

^a Department of Internal Medicine ^*  (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Endothelium; Haematocrit; Haemoglobin; Nitric oxide

Indexed keywords

ACETYLCHOLINE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; NITROPRUSSIDE SODIUM;

ADULT; ARTICLE; BLOOD RHEOLOGY; BODY MASS; CARDIOVASCULAR DISEASE; CELL FUNCTION; CHOLESTEROL BLOOD LEVEL; COMORBIDITY; CONTROLLED STUDY; DOSE RESPONSE; ERYTHROCYTE; FEMALE; FOREARM BLOOD FLOW; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HUMAN; HYPERTENSION; IN VITRO STUDY; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RESISTANCE BLOOD VESSEL; SMOKING; VASCULAR ENDOTHELIUM; VASODILATATION;

ACETYLCHOLINE; BLOOD FLOW VELOCITY; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FEMALE; FOREARM; HEMATOCRIT; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; MIDDLE AGED; NITROPRUSSIDE; THIAZOLIDINEDIONES; VASCULAR RESISTANCE; VASODILATION; VASODILATOR AGENTS;

EID: 14644420878     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi113     Document Type: Article

References (21)

1. Danesh J, Collins R, Peto R, Lowe, GD. Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease. Eur Heart J 2000;21:515-520.
2. Froom P. Blood viscosity and the risk of death from coronary heart disease. Eur Heart J 2000;21:513-514.
3. Lowe G, Rumley A, Norrie J et al. Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland Coronary Prevention Study. Thromb Haemost 2000;84:553-558.
4. Butler A, Megson I, Wright P. Diffusion of nitric oxide and scavenging by blood in the vasculature. Biochim Biophys Acta 1998;1425:168-176.
5. Gow AJ, Luchsinger BP, Pawloski JR et al. The oxyhemoglobin reaction of nitric oxide. Proc Natl Acad Sci USA 1999;96:9027-9032.
6. Cannon R, Schechter A, Panza Y et al. Effects of inhaled nitric oxide on regional blood flow are consistent with intravascular nitric oxide delivery. J Clin Invest 2001;108:279-287.
7. Neunteufl T, Heher S, Stefenelli T et al. Endothelial dysfunction in patients with polycythaemia vera. Br J Haematol 2001;115:354-359.
8. Giannattasio C, Piperno A, Failla M et al. Effects of hematocrit changes on flow-mediated and metabolic vasodilation in humans. Hypertension 2002;40:74-77.
9. Natali A, Baideweg S, Toschi E et al. Vascular effects of improving metabolic control with metformin or rosiglitazone in type 2 diabetes. Diabetes Care 2004;27:1349-1357.
10. Huang PL, Huang Z, Mashimo H et al. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995;377:239-242.
11. Cirillo M, Laurenzi M, Trevisan M et al. Hematocrit, blood pressure, and hypertension. The Gubbio Population Study. Hypertension 1992;20:319-326.
12. Carter C, McGee D, Reed D et al. Hematocrit and the risk of coronary heart disease: the Honolulu Heart Program, Am Heart J 1983;105:674-679.
13. Wannamethee SG, Perry IJ, Shaper AG. Hematocrit and risk of NIDDM. Diabetes 1996;45:576-579.
14. Barbieri M, Ragno E, Benvenuti E et al. New aspects of the insulin resistance syndrome: impact on haematological parameters, Diabetologia 2001;44:1232-1237.
15. Perticone F, Ceravolo R, Pujia A et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 2001;104:191-196.
16. Heitzer T, Schlinzig T, Krohn K et al. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001;104:2673-2678.
17. Joshi MS, Ferguson TB, Jr, Han TH et al. Nitric oxide is consumed, rather than conserved, by reaction with oxyhemoglobin under physiological conditions. Proc Natl Acad Sci USA 2002;99:10341-10346.
18. Wennmalm A, Benthin G, Petersson AS. Dependence of the metabolism of nitric oxide (NO) in healthy human whole blood on the oxygenation of its red cell haemoglobin. Br J Pharmacol 1992;106:507-508.
19. Anand IS, Chandrashekhar Y, Ferrari R et al. Pathogenesis of oedema in chronic severe anaemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones. Br Heart J 1993;70:357-362.
20. Eckardt KU. Anaemia in end-stage renal disease: pathophysiological considerations. Nephrol Dial Transplant 2001;16(suppl. 7):2-8.
21. Okasora T, Okamoto E, Kuwata K et al. Serum and erythrocyte acetylcholine esterase in Hirschsprung's disease, Z Kinderchir 1983;38:298-300.